北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第三临床医学院  > 内分泌科  > 期刊论文
学科主题: 内分泌
题名:
利拉鲁肽对人胰腺癌细胞增殖和凋亡的影响及可能机制
其他题名: Effect and mechanism of liraglutide on proliferation and apoptosis of human pancreatic cancer cells
作者: 魏蕊; 杨进; 洪天配; 赵荷珺; 柯静; 侯文芳; 刘烨
关键词: 胰升糖素样肽 1 ; 利拉鲁肽 ; 人胰腺癌细胞 ; 增殖 ; 凋亡 ; Glucagon-like peptide-1 ; Liraglutide ; Human pancreatic cancer cells ; Proliferation ; Apoptosis
刊名: 中华内分泌代谢杂志
发表日期: 2015
DOI: 10.3760/cma.j.issn.1000-6699.2015.06.014
期: 6, 页:530-534
收录类别: 中国科技核心期刊 ; 中文核心期刊 ; CSCD
文章类型: Journal Article
摘要: 目的:观察胰升糖素样肽1(GLP-1)受体激动剂利拉鲁肽对人胰腺癌细胞增殖和凋亡的影响,并初步探讨可能的作用机制。方法体外培养的人胰腺癌细胞系 MIA PaCa-2应用10~1000 nmol/ L利拉鲁肽干预24 h 或100 nmol/ L 利拉鲁肽干预0~72 h。 CCK-8试剂盒检测细胞增殖,RT-PCR 和 Western印迹检测相关基因的 mRNA 和蛋白表达水平。结果 MIA PaCa-2细胞系表达 GLP-1受体。利拉鲁肽可剂量和时间依赖性抑制胰腺癌细胞增殖,上调促凋亡蛋白 Bax 的表达,抑制抗凋亡蛋白 Bcl2的表达。同时,利拉鲁肽还可剂量和时间依赖性抑制胰腺癌细胞的胰岛素受体( INSR)和胰岛素样生长因子1受体(IGF-1R)的表达,并且抑制下游信号分子 Erk1/2和 Akt 蛋白的磷酸化水平。结论利拉鲁肽可抑制人胰腺癌细胞增殖和促进其凋亡,其抑癌效应可能是通过下调 INSR 和 IGF-1R 的表达,继而抑制 MEK/ Erk1/2和 PI3k/ Akt 信号通路所介导的。 Objective To investigate the effects and mechanism of glucagon-like peptide-1 ( GLP-1 ) receptor agonist liraglutide on the proliferation and apoptosis of human pancreatic cancer cells. Methods The human pancreatic cancer cell line MIA PaCa-2 was incubated for 24 h with liraglutide at various concentrations (10-1 000 nmol/ L), or with 100 nmol/ L liraglutide for various durations (0-72 h). Cell proliferation was determined by Cell Counting Kit-8 (CCK-8) analysis. RT-PCR and Western blot were used to detect the mRNA and protein expression levels of related genes. Results GLP-1 receptor was expressed in the MIA PaCa-2 cells. Liraglutide suppressed cell proliferation, up-regulated the expression levels of pro-apoptotic protein Bax and down-regulated the expression levels of anti-apoptotic protein Bcl2 in human pancreatic cancer cells in a dose- and time-dependent manner. Meanwhile, liraglutide down-regulated the expression levels of insulin receptor (INSR) and insulin-like growth factor-1 receptor (IGF-1R), and the phosphorylation levels of their downstream signaling proteins Erk1 / 2 and Akt, in a dose- and time-dependent way. Conclusion Liraglutide inhibits proliferation and promotes apoptosis of human pancreatic cancer cells; the process may be mediated via suppressing the expression of INSR and IGF-1R and inhibiting activation of the downstream MEK/ Erk1 / 2 and PI3k/ Akt pathways.
语种: 中文
原文出处: 查看原文
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/72786
Appears in Collections:北京大学第三临床医学院_内分泌科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 100191,北京大学第三医院内分泌科

Recommended Citation:
魏蕊,杨进,洪天配,等. 利拉鲁肽对人胰腺癌细胞增殖和凋亡的影响及可能机制[J]. 中华内分泌代谢杂志,2015(6):530-534.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[魏蕊]'s Articles
[杨进]'s Articles
[洪天配]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[魏蕊]‘s Articles
[杨进]‘s Articles
[洪天配]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace